Tart Cherry Inflammation Randomized Trial: What the Evidence Says

Quick Answer

Tart Cherry Inflammation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• An alarming 40-70% of older adults are estimated to have chronic sleep problems, which consequently increases the risk of detrimental health outcomes, including physical ailments, mental health issues, and cognitive decline. [VanderMark Esther (2026); evidence level 2]
• Thus, there is an urgent need to identify safe, non-pharmacological strategies that optimize sleep to support healthy aging in older adults and to minimize adverse outcomes that result from poor sleep. [VanderMark Esther (2026); evidence level 2]
• Accumulating evidence suggests that supplementation with fruit high in polyphenols may have beneficial effects on athletic performance and post-exercise recovery potentially due to their anti-oxidative and anti-inflammatory properties. [Zhu Yong (2026); evidence level 3]
• Among these, tart cherries have received increased attention by both researchers and consumers. [Zhu Yong (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For tart cherry inflammation randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• VanderMark Esther (2026). CherryZZZ: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study Testing Tart Cherry Juice in Older Adults with Self-Reported Insomnia. DOI: 10.3390/nu18060922. PMCID: PMC13029778. PMID: 41901097. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13029778/
• Zhu Yong (2026). The effect of Montmorency tart cherry consumption on athletic performance and post-exercise recovery in healthy adults: a scoping review. DOI: 10.3389/fnut.2026.1794292. PMCID: PMC13173514. PMID: 42146083. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13173514/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.